Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Global | Publication | February 2024
Africa is rich in mineral resources that have been traded internationally for many years through Global Value Chains (GVCs). GVCs refer to international production sharing where the different stages of the production process are located across different countries. In a robust panel discussion held at the 2024 Mining Indaba, esteemed panellists engaged on GVCs, their significant feature in world trade and notably, creating an attractive investment environment and support towards Africa’s priorities.
The key takeaways from the panel on how African States ought to diversify GVCs included:
The African Minerals Strategy Group (AMSG) was formed at the Future Minerals Conference held in Saudi Arabia in January 2024. The fundamental purpose of this group is to unite Africans and maximise benefits from the continent’s mineral resources. Reports indicate that 15 countries have pledged their support towards this cause and there are expectations that more countries will join the AMSG. The appointment of Nigeria’s Minister of Solid Minerals Development, Dr Oladele Alake’s as the chairperson of the group, has inspired confidence that Africa’s placement within the global value chain will be emphasised and prioritised.
The diversification of GVCs overlaps local and international legal regimes. Our cross-border service offering and industry experts are well equipped to advise companies across all value chains, from preproduction to postproduction.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023